MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

240.97 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,525
Open 240.97
Bid (Size) 239.00 (100)
Ask (Size) 242.00 (500)
Prev. Close 240.97
Today's Range 240.97 - 240.97
52wk Range 141.50 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.16%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗
Could this player be heading into a new era of growth? 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval... 
Via MarketMinute
Topics Artificial Intelligence

Performance

YTD
+16.2%
+16.2%
1 Month
-0.7%
-0.7%
3 Month
+17.9%
+17.9%
6 Month
+28.1%
+28.1%
1 Year
+60.0%
+60.0%

More News

Read More
News headline image
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
Via MarketMinute
Johnson & Johnson (NYSE:JNJ) Stands Out as a Quality Dividend Stock for Reliable Income ↗
Via Chartmill
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
Via MarketMinute
Topics Economy World Trade
News headline image
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
Via MarketMinute
News headline image
Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗
Via The Motley Fool
Topics Economy Energy
News headline image
JEPI vs. JEPQ: Which Is the Better Buy in April? ↗
Via The Motley Fool
Topics Bonds ETFs Economy
News headline image
Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?
Via Barchart.com
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
Via MarketMinute
Topics Economy Retirement
News headline image
This Healthcare Stock Barely Flinches During Market Sell-Offs ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm ↗
Via The Motley Fool
Topics Economy
News headline image
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation. ↗
Via The Motley Fool
Topics Economy
News headline image
The Dividend King That's Raised Its Payout for 63 Consecutive Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Via Finterra
Topics Lawsuit Product Recall
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is Intuitive Surgical a Buy Right Now? ↗
Via The Motley Fool
Topics World Trade
News headline image
2 Stocks I Plan to Hold for the Next 20 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
A Q2 2026 Playbook for Navigating Market Uncertainty ↗
Via MarketBeat
News headline image
What You Need To Know Ahead of Johnson & Johnson's Earnings Release
Via Barchart.com
Topics ETFs
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
The Fear Gauge Ascendant: VIX Hits 26 as Geopolitical Storms and 'Higher-for-Longer' Reality Grip Markets
Via MarketMinute
Topics Derivatives Economy Stocks
News headline image
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
Via MarketMinute

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 240.97
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/06/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 633.43B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 633B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story